Targeting Endothelial Function to Treat Heart Failure with Preserved Ejection Fraction: The Promise of Exercise Training

Although the burden of heart failure with preserved ejection fraction (HFpEF) is increasing, there is no therapy available that improves prognosis. Clinical trials using beta blockers and angiotensin converting enzyme inhibitors, cardiac-targeting drugs that reduce mortality in heart failure with re...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oxid Med Cell Longev
Asıl Yazarlar: Gevaert, Andreas B., Lemmens, Katrien, Vrints, Christiaan J., Van Craenenbroeck, Emeline M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2017
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494585/
https://ncbi.nlm.nih.gov/pubmed/28706575
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/4865756
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller